HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

RPX7009

a beta-lactamase inhibitor; structure in first source

Also Known As:

(2-hydroxy-3-(2-thiophen-2-ylacetylamino)(1,2)oxaborinan-6-yl)acetic acid

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Inorganic Chemicals: 9
- Acids: 53217
  - Noncarboxylic Acids
    - Boronic Acids: 200
      - RPX7009: 1
- Boron Compounds: 91
  - Boronic Acids: 200
    - RPX7009: 1
Organic Chemicals: 133
- Boron Compounds: 91
  - Boronic Acids: 200
    - RPX7009: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - RPX7009: 1

Experts

1.	Dudley, Michael N: 1 article (12/2015)
2.	Durso, Stephanie: 1 article (12/2015)
3.	Gotfried, Mark H: 1 article (12/2015)
4.	Griffith, David C: 1 article (12/2015)
5.	Loutit, Jeffrey S: 1 article (12/2015)
6.	Rodvold, Keith A: 1 article (12/2015)
7.	Wenzler, Eric: 1 article (12/2015)

Related Diseases

1.

Respiratory Tract Infections (Respiratory Tract Infection)

12/01/2015 - "Meropenem concentrations in AMs were below the quantitative limit of detection, whereas median concentrations of RPX7009 in AMs ranged from 2.35 to 6.94 μg/ml. The results from the present study lend support to exploring a fixed combination of meropenem (2 g) and RPX7009 (2 g) for the treatment of lower respiratory tract infections caused by meropenem-resistant Gram-negative pathogens susceptible to the combination of meropenem-RPX7009. "

Related Drugs and Biologics

1.	Meropenem (Merrem)